Where’s the relief from drug pricing fury?

Pharma IQ
Posted: 09/05/2017
As pharma spend continues to climb, so does public scrutiny on drug pricing. Once again, medicine manufacturers are spurred to strike a fair solution to balance raging its R&D appetites with affordable access to treatments for patients
Pharma IQ
Posted: 09/05/2017